Chondroitin Sulfate as a Key Molecule in the Development of Atherosclerosis and Cancer Progression
Authors:
- 1 January 2006
- book chapter
- Published by Elsevier
- Vol. 53, 281-295
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Characterization of Heparin Affin Regulatory Peptide Signaling in Human Endothelial CellsJournal of Biological Chemistry, 2005
- Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Retrovirally Mediated Overexpression of Versican V3 Reverses Impaired Elastogenesis and Heightened Proliferation Exhibited by Fibroblasts from Costello Syndrome and Hurler Disease PatientsThe American Journal of Pathology, 2004
- Extracellular matrix in vascular morphogenesis and disease: structure versus signalTrends in Cell Biology, 2003
- Identification of the Proteoglycan Binding Site in Apolipoprotein B48Journal of Biological Chemistry, 2002
- Human Coronary Smooth Muscle Cells Internalize Versican-Modified LDL Through LDL Receptor–Related Protein and LDL ReceptorsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Binding of a Large Chondroitin Sulfate/Dermatan Sulfate Proteoglycan, Versican, to L-selectin, P-selectin, and CD44Journal of Biological Chemistry, 2000
- Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectinInternational Immunology, 1999
- PROTEOGLYCANS: STRUCTURES AND INTERACTIONSAnnual Review of Biochemistry, 1991
- Specificity of the low density lipoprotein-glycosaminoglycan interaction.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991